An uncommon variant in the pre-AIDS era, lues maligna is a nodularulcerative form of secondary syphilis. We present a case of a 41-year-old man with HIV infection who developed fever, chills, nausea, vomiting, right upper quadrant abdominal pain, weight loss, watery diarrhea, and a painless, nonpruritic rash. He had diffuse nodular-ulcerative lesions in various stages of development. He was found to have a CD4 count of 101 cells/mm 3 (22%), an HIV viral load of 2,735,060 copies/mL, and a positive rapid plasma reagin at 1:64. He was started on emtricitabine, tenofovir, and dolutegravir, as well as doxycycline. He was given benzathine penicillin 2.4 million units intramuscularly and within hours developed a Jarisch-Herxheimer reaction. Skin lesions showed signs of healing, and constitutional symptoms improved 48 hours later. W e describe a nodular-ulcerative form of secondary syphilis in a patient with AIDS, characterized by some remarkable clinical and laboratory features. Th e alarming resurgence of syphilis and high coinfection rates with HIV necessitate clinicians' familiarity with this manifestation of "the great imitator."
CASE PRESENTATION
A 41-year-old man with a history of intravenous drug abuse and untreated HIV infection presented to his primary care physician with complaints of fever, chills, nausea, vomiting, right upper quadrant abdominal pain, weight loss, watery diarrhea, and a diff use painless, nonpruritic nodular-ulcerative rash. He was malnourished, febrile (101.2°F), tachycardic, and in mild respiratory distress, with tender and enlarged cervical lymph nodes and mild right upper quadrant tenderness. A diffuse nodulo-ulcerative rash was present, with lesions in various stages of development involving the extremities, back, chest, face, and scalp, as well as a few lesions on his soles, but sparing the palms and the oral mucosa ( Figure ) .
Th e patient was found to have a CD4 count of 101 cells/mm 3 (22%), an HIV viral load of 2,735,060 copies/mL, a reactive treponemal antibody, and a positive rapid plasma reagin (RPR) titer at 1:64. He reported an unprotected sexual encounter with a male partner 4 months prior to the appearance of the rash. He was started on combination antiretroviral therapy with emtricitabine, tenofovir, and dolutegravir, trimethoprim-sulfamethoxazole for Pneumocystis jirovecii pneumonia prophylaxis, as well as doxycycline for presumptive secondary syphilis, given a reported allergy to penicillin.
He was admitted to the hospital a few days later with worsening constitutional symptoms. His white blood cell count was 3.3 k/mm 3 ; hemoglobin, 9.6 k/mm 3 ; aspartate aminotransferase, 81 IU/L; alanine aminotransferase, 64 IU/L; and alkaline phosphatase, 644 IU/L. Right upper quadrant ultrasound was unremarkable.
Th e patient had had a nonanaphylactic cutaneous reaction to penicillin previously. In the hospital he was given benzathine penicillin 2.4 million units intramuscularly. Within hours he developed worsening fever, tachycardia, and tachypnea, thought to be a Jarisch-Herxheimer reaction. Within 48 hours of treatment, his skin lesions showed signs of healing, and signifi cant improvement was noted by the time of hospital discharge 5 days later. He received 2 more weekly penicillin injections as an outpatient, and 1 week after the third injection he reported almost complete resolution of the rash. At that time, his RPR titer was 1:512. He was subsequently lost to follow-up.
DISCUSSION
Syphilis is well known for its protean cutaneous manifestations, which led early clinicians to christen the disease "the great imitator." Lues maligna, or nodular-ulcerative syphilis, is a rare but severe manifestation of secondary syphilis fi rst described by Bazin in 1859, with early systematic studies by Haslund and Neisser in the late 1800s ( 1, 2 ) . Th e term "malignant" has been used to describe its grotesque clinical features ( 3 ).
Lues maligna is characterized by marked prodromal constitutional symptoms, as observed in our patient. Th is is followed by the development of multiple irregularly distributed, erythematous papules that subsequently evolve into well-defi ned round or oval, necrotic ulcerated plaques on the scalp, face, trunk, and extremities. Lesions in various stages of development, including papules, nodules, pustules, and ulcerations covered with laminated, brown-black rupioid crusts are present, and mucosal surfaces may be aff ected ( 1 ) . Th e trunk, palms of the hands, soles of the feet, and mucosal membranes can be involved, but to a lesser degree than in typical secondary syphilis ( 3 ). Our patient had a few lesions on the soles, but his palms and mucosal membranes were spared.
Th e liver is the most commonly involved extracutaneous organ ( 3 ). Our patient had right upper quadrant abdominal pain and elevation of liver enzymes, likely due to syphilis.
Fisher's criteria are usually used for diagnosing malignant syphilis: 1) compatible gross morphology; 2) a high-titer serologic test for syphilis; 3) a Jarisch-Herxheimer reaction following treatment; and 4) a dramatic response to antibiotic therapy ( 3 ). All of these manifestations were present in our patient.
Th e histologic fi ndings in secondary syphilis are as varied as the clinical presentations. Features mimicking persistent gyrate erythema, lichen planus, parapsoriasis lichenoides and varioliformis acuta, erythema exudativum, psoriasis, pustular psoriasis, histiocytoma, and sarcoidosis have been described ( 4 ) . Lues maligna is characterized by occlusion of the blood vessels with resultant fi brinoid necrosis at the dermal-subcutaneous junction. Treponemes are not readily identifi ed in the lesions but have been described in the dermis using a Warthin-Starry stain ( 3 ) .
Th e incidence of primary and secondary syphilis has been increasing in the USA in the last several years, especially in men who have sex with men, with the largest increases among Hispanic and white men. Despite this shift in epidemiology, the highest rates continue to occur in black men ( 5 ) . Th e prevalence of lues maligna was 0.36% in Haslund's original series ( 2 ) . In the pre-AIDS era, lues maligna was associated with severe malnutrition, alcoholism, and intravenous drug use ( 6 ) . Following the AIDS epidemic, the incidence of malignant syphilis signifi cantly increased ( 6 ) . According to a 1996 multicenter retrospective study, patients with HIV were 60 times more likely to present with ulcerative syphilis compared to historic case series ( 2 ) .
Th e reasons for atypical manifestations in the setting of HIV are not entirely understood. It is known that the pathogenesis of lues maligna is less dependent on specifi c treponemal virulence factors and more infl uenced by the host's immune state, as patients can acquire the disease from persons with typical manifestations of syphilis ( 1 ) . Th ere are also important clinical interactions between syphilis and HIV, as syphilis is associated with the transmission and acquisition of HIV infection. Syphilitic ulcers facilitate transmission of HIV, and syphilis stimulates the immune system, which can lead to an increase in HIV replication and lower CD4 counts ( 7 ) .
An increase in the incidence of Jarisch-Herxheimer reactions has been described among patients with malignant syphilis and patients coinfected with HIV in general. Yang et al described a rate as high as 34.6% in HIV-infected patients ( 8 ) . Th e Jarisch-Herxheimer reaction is a transient immunological phenomenon seen commonly in patients during treatment of secondary syphilis; it manifests with constitutional symptoms such as fever, chills, headache, and myalgias in addition to exacerbation of existing cutaneous lesions ( 9 ) . Th e reaction usually occurs soon after the administration of an appropriate antibiotic (2-24 hours) and usually resolves without any intervention, generally within 24 hours. Jarisch-Herxheimer reaction is more severe when the number of organisms is abundant ( 9 ) . No specifi c tests are available to diagnose Jarisch-Herxheimer reaction. It should be managed symptomatically and does not require discontinuation of the appropriate antimicrobial treatment ( 9 ) . Corticosteroids have been used to off set the reaction with no conclusive evidence of their benefi t ( 9 ). Pretreatment with anti-tumor necrosis factor-alfa Fab has been shown to reduce the incidence and severity of the reaction in louse-borne relapsing fever ( 10 ), but its role in syphilis and its potential therapeutic value is unknown.
Th e Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines recommend a follow-up nontreponemal serologic test of syphilis patients 6 and 12 months after therapy ( 11 ) . Repeat syphilis testing before these specifi ed times can create confusion, as the RPR may increase immediately after therapy of early syphilis, and the initial RPR may underestimate the maximal titer ( 12 ) . In our case, the early rise in RPR posttherapy was uninterpretable, but likely was not signifi cant. Unfortunately, the patient was lost to follow-up, so the subsequent response is unknown.
